Dec 23, 2020 Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement Learn More
Dec 22, 2020 Cellectar Biosciences Announces Proposed Underwritten Public Offering and Concurrent Private Placement Learn More
Nov 9, 2020 Cellectar Reports Third Quarter 2020 Financial Results and Provides a Corporate Update Learn More
Nov 5, 2020 Cellectar Biosciences’ CLR 131 Demonstrates Preliminary Activity in Phase I Study for Pediatric Brain and Solid Tumors Learn More